NASDAQ:TLPH Talphera (TLPH) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free TLPH Stock Alerts $1.05 -0.07 (-6.25%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.02▼$1.0850-Day Range$0.93▼$1.5052-Week Range$0.43▼$1.61Volume39,887 shsAverage Volume119,048 shsMarket Capitalization$17.82 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Talphera alerts: Email Address Talphera MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside471.4% Upside$6.00 Price TargetShort InterestHealthy0.65% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.12) to ($1.06) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 starsMedical Sector598th out of 913 stocksPharmaceutical Preparations Industry266th out of 420 stocks 3.5 Analyst's Opinion Consensus RatingTalphera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageTalphera has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.65% of the float of Talphera has been sold short.Short Interest Ratio / Days to CoverTalphera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Talphera has recently decreased by 6.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTalphera does not currently pay a dividend.Dividend GrowthTalphera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TLPH. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Talphera this week, compared to 16 articles on an average week.Search InterestOnly 1 people have searched for TLPH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Talphera to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Talphera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.00% of the stock of Talphera is held by insiders.Percentage Held by InstitutionsOnly 37.67% of the stock of Talphera is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Talphera are expected to grow in the coming year, from ($1.12) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Talphera is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Talphera is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTalphera has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Talphera Stock (NASDAQ:TLPH)Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.Read More TLPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TLPH Stock News HeadlinesApril 25, 2024 | finance.yahoo.comTalphera, Inc. (TLPH)April 24, 2024 | americanbankingnews.comTalphera (NASDAQ:TLPH) Stock Price Up 1.7%April 27, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 13, 2024 | finance.yahoo.comTalphera, Inc. (TLPH) Stock Historical Prices & Data - Yahoo FinanceMarch 21, 2024 | msn.com5 years after it was yanked off stores, GOG's bringing underrated spy RPG Alpha Protocol in from the cold with fewer crashes and new achievementsMarch 20, 2024 | msn.comAlpha Protocol Finally Available Again Five Years After Being DelistedMarch 20, 2024 | seekingalpha.comTaysha: Initial Rett Syndrome Data Leads To Other 2024 CatalystsMarch 20, 2024 | msn.comCult classic spy RPG Alpha Protocol is back on PC after being delisted in 2019April 27, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)March 20, 2024 | msn.comAlpha Violet Propels ‘Identifying Features’ Directors’ Unconventional Sundance-Winning Cartel Narrative ‘Sujo’ to Cross Borders (EXCLUSIVE)March 20, 2024 | msn.comWolf Dogs vs. Alpha Academy stipulation match announced for next WWE NXTMarch 20, 2024 | msn.comAlpha Group: fintech reports growth as it eyes premium listing in 2024March 20, 2024 | msn.comUpcoming WWE NXT: Breakker and Corbin Team Up Against Alpha AcademyMarch 19, 2024 | msn.comMMOs collide as one fan recreates RuneScape using World of Warcraft assets, and after 9 months of work is getting close to an honest-to-god alpha buildMarch 19, 2024 | msn.comDonald Trump looks 'power-riddled' as he tries to be the 'alpha' in interview with Nigel FarageMarch 19, 2024 | finance.yahoo.comDubai-based Cryptocurrency Venture Capital 'Alpha Token Capital' Invests in $CVTXMarch 19, 2024 | msn.comGen Alpha-geared Brand Subdued Gets InvestmentMarch 19, 2024 | msn.comWhat Is Generation Alpha? Meaning, Characteristics, and FutureMarch 19, 2024 | msn.comVindictus: Defying Fate Preview: Visually Stunning Pre-Alpha PlaytestMarch 18, 2024 | msn.comUnderstanding the Alpha Female: A Guide to Embracing Your Inner LeaderMarch 18, 2024 | msn.comElectoral Bonds Case: 'SBI has to reveal and present the alpha numeric number' says Supreme CourtMarch 18, 2024 | msn.comElectoral Bonds: What Are Unique Alpha-Numeric Numbers Asked By Supreme Court From SBI?March 18, 2024 | msn.comElectoral Bonds Data 2nd List LIVE: ASSOCHAM, FICCI and other industry organisations filed an application seeking deferment of hearing on SBI alpha numerical numbersMarch 17, 2024 | msn.comDonald Trump wanted to create an 'alpha rough guy presence' during unhinged 'bloodbath' speechMarch 16, 2024 | msn.comAlpha’s patriotic fundraiser prepares for the 4th of JulyMarch 16, 2024 | msn.comThese Are The Actual Age Ranges for Millennials, Gen Z, Gen Alpha & MoreMarch 16, 2024 | seekingalpha.comWeek Ahead: Central BanksSee More Headlines Receive TLPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Talphera and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today4/26/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TLPH Previous SymbolNASDAQ:TLPH CUSIPN/A CIK1427925 Webtalphera.com Phone650-216-3500Fax650-216-6500Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+476.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,400,000.00 Net MarginsN/A Pretax Margin-1,580.18% Return on Equity-71.67% Return on Assets-46.65% Debt Debt-to-Equity RatioN/A Current Ratio2.56 Quick Ratio2.56 Sales & Book Value Annual Sales$650,000.00 Price / Sales27.15 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book1.25Miscellaneous Outstanding Shares16,970,000Free Float16,460,000Market Cap$17.65 million OptionableOptionable Beta0.51 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Vincent J. Angotti (Age 56)CEO & Director Comp: $906.54kDr. Pamela Pierce Palmer M.D. (Age 61)Ph.D., Co-Founder & Chief Medical Officer Comp: $699.75kMr. Raffi Mark Asadorian (Age 55)Chief Financial Officer Comp: $637.5kMr. Anil N. Dasu (Age 61)Chief Engineering Officer Comp: $478.09kKey CompetitorsVincerx PharmaNASDAQ:VINCIndaptus TherapeuticsNASDAQ:INDPFSD PharmaNASDAQ:HUGEAlaunos TherapeuticsNASDAQ:TCRTBioVieNASDAQ:BIVIView All Competitors TLPH Stock Analysis - Frequently Asked Questions Should I buy or sell Talphera stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Talphera in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TLPH shares. View TLPH analyst ratings or view top-rated stocks. What is Talphera's stock price target for 2024? 1 brokerages have issued 12 month price objectives for Talphera's stock. Their TLPH share price targets range from $6.00 to $6.00. On average, they predict the company's share price to reach $6.00 in the next year. This suggests a possible upside of 471.4% from the stock's current price. View analysts price targets for TLPH or view top-rated stocks among Wall Street analysts. How have TLPH shares performed in 2024? Talphera's stock was trading at $0.7989 at the start of the year. Since then, TLPH shares have increased by 31.4% and is now trading at $1.05. View the best growth stocks for 2024 here. When is Talphera's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our TLPH earnings forecast. How were Talphera's earnings last quarter? Talphera, Inc. (NASDAQ:TLPH) announced its earnings results on Wednesday, March, 6th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.01. The business had revenue of $0.28 million for the quarter. How do I buy shares of Talphera? Shares of TLPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TLPH) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
